Benzinga | Sep 15, 2020 06:20AM EDT

SVB Leerink Maintains Outperform on Seattle Genetics, Raises Price Target to $185

SVB Leerink analyst Andrew Berens maintains Seattle Genetics (NASDAQ:SGEN) with a Outperform and raises the price target from $173 to $185.